| HC513016 |
Anti-Human Notch-2&Notch-3 Reference Antibody (Tarextumab |
Tarextumab (HC513016) is a research-grade recombinant antibody targeting N2ICD. Produced in mammalian cells with native-like glycosylation.
Highlights
●Research Grade — For PK/PD studies, assay development, and ADA research.
●Native Glycosylation — Mammalian expression ensures native-like patterns.
|
N2ICD, N2ECD, NOTCH2, hN2, Neurogenic locus notch homolog protein 2, Notch 2, Neurogenic locus notch homolog protein 3, NOTCH3, Notch 3 |
